Skip to main content Accessibility help
×
Home

Incidence and prevalence of Toxoplasma gondii infection in women in France, 1980–2020: model-based estimation

  • F. NOGAREDA (a1) (a2), Y. LE STRAT (a1), I. VILLENA (a3), H. DE VALK (a1) and V. GOULET (a1)...

Summary

Toxoplasmosis is a worldwide zoonosis due to Toxoplasma gondii, a ubiquitous protozoan parasite of warm-blooded animals including humans. In pregnant women, primary infection can cause congenital toxoplasmosis resulting in severe malformations in the newborn. Since 1978, public health authorities in France have implemented a congenital toxoplasmosis prevention programme, including monthly serological screening of all seronegative pregnant women, and treatment in case of seroconversion. However, this programme does not produce systematic surveillance data on incidence and prevalence. Our objective was to estimate the incidence and prevalence of T. gondii infection, and the incidence of seroconversion during pregnancy in women in France. We used a catalytic model to estimate incidence and prevalence of Toxoplasma infection between 1980 and 2020 in women of childbearing age. We used age- and time-specific seroprevalence data obtained from the National Perinatal Surveys (NPS) conducted in 1995, 2003 and 2010. We assumed that incidence depends both on age and calendar time, and can be expressed as the product of two unknown functions. We also estimated incidence of seroconversion during pregnancy in 2010 from the NPS and the National Surveillance of Congenital Toxoplasmosis (ToxoSurv). We combined data of 42208 women aged 15–45 years with serology available from the three NPS. For women aged 30 years the modelled incidence decreased from 7·5/1000 susceptible women in 1980 to 3·5/1000 in 2000. In 2010 the incidence was 2·4/1000. The predicted incidence and prevalence for 2020 was 1·6/1000 and 27%, respectively. The incidence of seroconversion during pregnancy in 2010 was estimated at 2·1/1000 susceptible pregnant women (95% CI 1·3–3·1) from the NPS and 1·9 (95% CI 1·8–2·1) from ToxoSurv. Incidence and prevalence of Toxoplasma infection has decreased markedly during the last 30 years. This decrease may be explained by a lower exposure to the parasite by changes in food habits and by improved hygiene practices in meat production. Modelled estimations were consistent with estimates observed in other studies conducted previously in France. The catalytic modelling provides reliable estimates of incidence and prevalence of Toxoplasma infection over time. This approach might be useful for evaluating preventive programme for toxoplasmosis.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Incidence and prevalence of Toxoplasma gondii infection in women in France, 1980–2020: model-based estimation
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Incidence and prevalence of Toxoplasma gondii infection in women in France, 1980–2020: model-based estimation
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Incidence and prevalence of Toxoplasma gondii infection in women in France, 1980–2020: model-based estimation
      Available formats
      ×

Copyright

Corresponding author

*Author for correspondence: Dr Y. Le Strat, Department of Infectious Diseases, French Institute for Public Health Surveillance, Saint-Maurice, France, 12 rue du Val d'Osne, 94415 Saint-Maurice cedex, France. (Email: y.lestrat@invs.sante.fr)

References

Hide All
1.Chin, J. Control of Communicable Disease Manual, 17th edn. American Public Health Association, 2000.
2.Dubey, JP. Toxoplasma gondii. In: Baron, S, ed. Medical Microbiology, 4th edn. Gavelston, TX: University of Texas Medical Branch at Galveston, 1996.
3.Benenson, MW, et al. Oocyst-transmitted toxoplasmosis associated with ingestion of contaminated water. New England Journal of Medicine 1982; 307: 666669.
4.Nissapatorn, V, et al. Toxoplasmosis: prevalence and risk factors. Journal of Obstetrics and Gynaecology 2003; 23: 618624.
5.Jones, JL, et al. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. American Journal of Epidemiology 2001; 154: 357365.
6.Allain, JP, Palmer, CR, Pearson, G. Epidemiological study of latent and recent infection by Toxoplasma gondii in pregnant women from a regional population in the U.K. Journal of Infection 1998; 36: 189196.
7.Petersson, K, et al. Seroprevalence of Toxoplasma gondii among pregnant women in Sweden. Acta Obstetricia et Gynecologica Scandinavica 2000; 79: 824829.
8.Fuente, MC, Bovone, NS, Cabral, GE. Prophylaxis of prenatal toxoplasmosis [in Spanish]. Medicina (Buenos Aires) 1997; 57: 155160.
9.Bouratbine, A, et al. Sero-epidemiologic profile of toxoplasmosis in northern Tunisia [in French]. Parasite 2001; 8: 6166.
10.el-Nawawy, A, et al. Maternal and neonatal prevalence of toxoplasma and cytomegalovirus (CMV) antibodies and hepatitis-B antigens in an Egyptian rural area. Journal of Tropical Pediatrics 1996; 42: 154157.
11.Faye, O, et al. Toxoplasmosis in Dakar. Seroepidemiologic sampling of 353 women of reproductive age [in French]. Bulletin de la Société de Pathologie Exotique 1998; 91: 249250.
12.Guebre-Xabier, M, et al. Sero-epidemiological survey of Toxoplasma gondii infection in Ethiopia. Ethiopian Medical Journal 1993; 31: 201208.
13.az-Suarez, O, et al. Seroepidemiology of toxoplasmosis in a Yucpa Amerindian community of Sierra de Perija, Zulia State, Venezuela [in Spanish]. Revista Médica de Chile 2003; 131: 10031010.
14.Blondel, B, et al. , The National Coordination Group of the National Perinatal Surveys. Trends in perinatal health in France from 1995 to 2010. Results from the French National Perinatal Surveys. Journal de Gynécologie Obstétrique et Biologie de la Reproduction 2012.
15.Desmonts, G, Couvreur, J, Ben, Rachid MS. Toxoplasmosis, the mother and the child [in French]. Archives Françaises de Pédiatrie 1965; 22: 11831200.
16.National Laboratory of Health. Immunity and Toxoplasma infection in pregnant women in France [in French]. Bulletin Epidémiologique Hebdomadaire 1984; 51: 23.
17.Ancelle, T, et al. Toxoplasmosis among pregnant women in France in 1995 [in French]. Bulletin Epidémiologique Hebdomadaire 1995; 51: 227229.
18.Berger, F, et al. Toxoplasmosis among pregnant women in France: risk factors and change of prevalence between 1995 and 2003. Revue d'Epidémiologie et de Santé Publique 2009; 57: 241248.
19.Montoya, JG, Liesenfeld, O. Toxoplasmosis. Lancet 2004; 363: 19651976.
20.Dunn, D, et al. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 1999; 353: 18291833.
21.Wallon, M, et al. Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years. Clinical Infectious Diseases 2013; 56: 12231231.
22.Journal Officiel de la République Française. Decree 92-143 on mandatory premarital, prenatal and postnatal examinations, 14 February 1992.
23.French National Authority for Health. Serological surveillance and prevention of toxoplasmosis and rubella during pregnancy. Public Health recommendations of the French National Authority for Health, 2009.
24.Thiebaut, R, et al. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients’ data. Lancet 2007; 369: 115122.
25.Moncada, PA, Montoya, JG. Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment. Expert Review of Anti-infective Therapy 2012; 10: 815828.
26.Papoz, L, et al. A simple model relevant to toxoplasmosis applied to epidemiologic results in France. American Journal of Epidemiology 1986; 123: 154161.
27.Ades, AE, Nokes, DJ. Modeling age- and time-specific incidence from seroprevalence: toxoplasmosis. American Journal of Epidemiology 1993; 137: 10221034.
28.National Perinatal Survey. French National Institute of Health and Medical Research (Inserm), 2012 (http://www.sante.gouv.fr/enquetes-nationales-perinatales.html).
29.King, L, et al. Congenital toxoplasmosis: implementation of a surveillance system in France. Bulletin Epidémiologique Hebdomadaire 2008; 14–15: 122124.
30.Villena, I, et al. Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Eurosurveillance 2010; 15.
31.National Institute of Statistics and Economic Studies (INSEE). (http://www.insee.fr/), 2012.
32.R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, 2011.
33.National Surveillance of Congenital Toxoplasmosis. ToxoSurv network (https://www.chu-reims.fr/professionnels/cnr-toxoplasmose-1/surveillance-de-la-toxoplasmose-congenitale/). 2012.
34.Baril, L, et al. Risk factors for Toxoplasma infection in pregnancy: a case-control study in France. Scandinavian Journal of Infectious Diseases 1999; 31: 305309.
35.Halos, L, et al. An innovative survey underlining the significant level of contamination by Toxoplasma gondii of ovine meat consumed in France. International Journal for Parasitology 2010; 40: 193200.
36.Department of Statistics and Forecasting. Agreste syntheses – consumption. French Ministry of Agriculture, Food, Fisheries, Rural Affairs and Spatial Planning. French Republic. 2010.
37.Ades, AE. Methods for estimating the incidence of primary infection in pregnancy: a reappraisal of toxoplasmosis and cytomegalovirus data. Epidemiology and Infection 1992; 108: 367375.
38.Armstrong, GL, Bell, BP. Hepatitis A virus infections in the United States: model-based estimates and implications for childhood immunization. Pediatrics 2002; 109: 839845.
39.Armstrong, GL, et al. Childhood hepatitis B virus infections in the United States before hepatitis B immunization. Pediatrics 2001; 108: 11231128.
40.Cutts, FT, Vynnycky, E. Modelling the incidence of congenital rubella syndrome in developing countries. International Journal of Epidemiology 1999; 28: 11761184.
41.Colugnati, FA, et al. Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC Infectious Diseases 2007; 7: 71.
42.Farrington, CP. Modelling forces of infection for measles, mumps and rubella. Statistics in Medicine 1990; 9: 953967.

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed